Semaglutide

Research-grade Semaglutide for metabolic and rejuvenation studies. Strictly for Research Use Only (RUO).

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist developed for metabolic regulation. This synthetic peptide mimics the natural GLP-1 hormone, enhancing insulin secretion in response to glucose levels while simultaneously reducing appetite signaling in the brain. By modulating both glucose homeostasis and satiety pathways, semaglutide addresses multiple physiological mechanisms involved in metabolic control. The compound demonstrates sustained activity through its extended half-life, allowing for less frequent dosing protocols. Research indicates its mechanism involves pancreatic beta-cell stimulation, delayed gastric emptying, and central nervous system appetite suppression. Semaglutide represents a significant advancement in peptide-based therapeutic approaches for metabolic health optimization.